César Yldifonso Salinas-Ulloa

César Yldifonso Salinas-Ulloa

Auto-generated profile, based on publicly available information

César Yldifonso Salinas-Ulloa

Instituto Nacional de Cardiología

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2018 in Malaria Journal
Verified
Journal Article
Open access
PDF file
SASara Avalos
Sara Avalos
RMRosa E. Mejia
Rosa E. Mejia
EBEngels Banegas
Engels Banegas
CSCesar Salinas
Cesar Salinas
LGLester Gutierrez
Lester Gutierrez
Gustavo FontechaGustavo Fontecha
Gustavo Fontecha
The incidence of malaria in the Americas has decreased markedly in recent years. Honduras and the other countries of Mesoamerica and the island of Hispaniola have set the goal of eliminating native malaria by the year 2020. To achieve this goal, Honduras has recently approved national regulations to expand the possibilities of a shortened double dose primaquine (PQ) treatment for vivax malaria. Considering this new shortened anti-malarial treatment, the high frequency of G6PDd genotypes in Honduras, and the lack of routinely assessment of the G6PD deficiency status, this study aimed at investigating the potential association between the intake of PQ and haemolysis in malaria-infected G6PDd subjects. This was a prospective cohort and open-label study. Participants with malaria were recruited. Plasmodium vivax infection was treated with 0.25 mg/kg of PQ daily for 14 days. Safety and signs of haemolysis were evaluated by clinical criteria and laboratory values before and during the 3rd and 7th day of PQ treatment. G6PD status was assessed by a rapid test (CareStart™) and two molecular approaches. Overall 55 participants were enrolled. The frequency of G6PD deficient genotypes was 7/55 (12.7%), where 5/7 (71.4%) were hemizygous A− males and 2/7 (28.6%) heterozygous A− females. Haemoglobin concentrations were compared between G6PD wild type (B) and G6PDd A− subjects, showing a significant difference between the means of both groups in the 3rd and 7th days. Furthermore, a statistically significant difference was evident in the change in haemoglobin concentration between the 3rd day and the 1st day for both genotypes, but there was no statistical difference for the change in haemoglobin concentration between the 7th day and the 1st day. Besides these changes in the haemoglobin concentrations, none of the patients showed signs or symptoms associated with severe haemolysis, and none needed to be admitted to a hospital for further medical attention. The findings support that the intake of PQ during 14 days of treatment against vivax malaria is safe in patients with a class III variant of G6PDd. In view of the new national regulations in the shortened treatment of vivax malaria for 7 days, it is advisable to be alert of potential cases of severe haemolysis that could occur among G6PD deficient hemizygous males with a class II mutation such as the Santamaria variant, previously reported in the country.

15 October 2024 in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
Verified
Journal Article
Open access
PDF file
OFOyuky Flores-Alamos
Oyuky Flores-Alamos
DGDiego González-Guzmán
Diego González-Guzmán
AAAntonio de Jesús Andrade-Ortega
Antonio de Jesús Andrade-Ortega
JPJaime Ponce-Gallegos
Jaime Ponce-Gallegos
ACAmayrani E. Coyac-Cavazos
Amayrani E. Coyac-Cavazos
Marco Ponce-GallegosMarco Ponce-Gallegos
Marco Ponce-Gallegos
Infective endocarditis is a disease that affects mainly the endocardial surface of the heart and cardiac valves (native or prosthetic). The main risk factors for developing infective endocarditis are male sex, older age, intracardiac shunts, prosthetic valves, rheumatic, and congenital heart disease, intracardiac devices, intravenous drugs use, immunosuppression, and hemodialysis. Streptococci and Staphylococci spp. have been the most frequent isolated organisms. On the other hand, the most common fungal organism in infective endocarditis is Candida albicans (24-46%), followed by Aspergillus spp. (25%), and a few cases by Cryptococcus neoformans, which are associated with higher rate of mortality. This case provides an interesting case of Cryptococcus neoformans native valve infective endocarditis in a young woman with stage IV chronic kidney disease and severe malnutrition.

19 July 2024 in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
Verified
Journal Article
Open access
PDF file
JPJaime Ponce-Gallegos
Jaime Ponce-Gallegos
JGJesús A. García-Diaz
Jesús A. García-Diaz
JPJose Jesus Alanis Ponce
Jose Jesus Alanis Ponce
CSCésar Yldifonso Salinas-Ulloa
César Yldifonso Salinas-Ulloa
JVJosé Pablo Velázquez-Padilla
José Pablo Velázquez-Padilla
Marco Ponce-GallegosMarco Ponce-Gallegos
Marco Ponce-Gallegos
We present the case of a woman in her third decade of life, known to have difficult-to-control mixed headaches and polycystic ovary syndrome under hormonal treatment. Without any other manifestation, the patient debuted with an acute coronary syndrome classified as unstable angina. Electrocardiogram showed anterior and lateral ST segment depression and ST elevation in aVR. Coronary computer tomography and coronary angiography showed evidence of significant obstruction of the left main coronary artery. The patient was diagnosed with systemic lupus erythematosus (SLE), and was classified as vasculitis secondary to SLE as an unusual initial manifestation.

28 April 2025 in Salus et Vita
Verified
Journal Article
Open access
PDF file
ODOdry Corina Díaz-Morales
Odry Corina Díaz-Morales
BDBayron Josué Degrandes-Rodríguez
Bayron Josué Degrandes-Rodríguez
CUCesar Yldifonso Salinas Ulloa
Cesar Yldifonso Salinas Ulloa
OGOlman Daniel Gradis-Santos
Olman Daniel Gradis-Santos
JSJhiamluka Solano
Jhiamluka Solano
El síndrome de Wolff-Parkinson-White (WPW) es un trastorno pre-excitatorio caracterizado por una vía accesoria entre aurículas y ventrículos, que puede generar arritmias graves, incluso muerte súbita. A menudo es asintomático y se detecta incidentalmente mediante un electrocardiograma (ECG). Este caso describe a un paciente masculino de 39 años con antecedentes de arritmias, manejado inicialmente con bisoprolol. Tras presentar episodios recurrentes de palpitaciones y disnea, se confirmó el diagnóstico de WPW con ECG y Holter, identificando una vía accesoria lateral derecha. El manejo incluyó tratamiento expectante y seguimiento en espera de ablación. La ablación con catéter es el tratamiento de primera línea en pacientes sintomáticos o con alto riesgo, con pronóstico favorable si se realiza a tiempo.